Literature DB >> 21886494

Commentary: clinical trials represent the best cancer care. Or do they?

Charles D Blanke.   

Abstract

Entities:  

Year:  2011        PMID： 21886494      PMCID： PMC3092653          DOI： 10.1200/JOP.2011.000253

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN： 1554-7477            Impact factor:   3.840


× No keyword cloud information.
  3 in total

1.  Characteristics and outcomes of patients with advanced gastric cancer who declined to participate in a randomized clinical chemotherapy trial.

Authors:  Chiharu Tanai; Takako Eguchi Nakajima; Kengo Nagashima; Ken Kato; Tetsuya Hamaguchi; Yasuhide Yamada; Kei Muro; Kuniaki Shirao; Hideo Kunitoh; Yasuhiro Matsumura; Seiichiro Yamamoto; Yasuhiro Shimada
Journal:  J Oncol Pract       Date:  2011-05       Impact factor: 3.840

Review 2.  Are randomized clinical trials good for us (in the short term)? Evidence for a "trial effect".

Authors:  D A Braunholtz; S J Edwards; R J Lilford
Journal:  J Clin Epidemiol       Date:  2001-03       Impact factor: 6.437

3.  Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials.

Authors:  C Tanai; H Nokihara; S Yamamoto; H Kunitoh; N Yamamoto; I Sekine; Y Ohe; T Tamura
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640
  3 in total
  1 in total

1.  Characteristics of amino acid metabolism in preterm infants in Guangxi, China.

Authors:  Cai-Juan Lin; Guo-Xing Geng; Zhen-Ren Peng; Xiao-Tao Huang; Liu-Lin Wu; Yu-Qi Xu; Wei Li; Jia-Le Qian; Jing-Si Luo
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.